Compile Data Set for Download or QSAR
Report error Found 62 Enz. Inhib. hit(s) with all data for entry = 10625
TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555248BDBM555248(USRE49080, Example 16)
Affinity DataIC50: 0.150nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555251BDBM555251(USRE49080, Example 21)
Affinity DataIC50: 0.200nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555247BDBM555247(USRE49080, Example 15)
Affinity DataIC50: 0.200nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555242BDBM555242(USRE49080, Example 8)
Affinity DataIC50: 0.25nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555255BDBM555255(USRE49080, Example 28)
Affinity DataIC50: 0.330nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555263BDBM555263(USRE49080, Example 42)
Affinity DataIC50: 0.350nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555252BDBM555252(USRE49080, Example 22)
Affinity DataIC50: 0.400nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50560402BDBM50560402(Licogliflozin | Lik066 | LIK-066 | USRE49080, Exam...)
Affinity DataIC50: 0.5nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555250BDBM555250(USRE49080, Example 20)
Affinity DataIC50: 0.550nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555249BDBM555249(USRE49080, Example 17)
Affinity DataIC50: 0.800nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555270BDBM555270(USRE49080, Example 66)
Affinity DataIC50: 0.900nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555257BDBM555257(USRE49080, Example 31)
Affinity DataIC50: 1.20nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555271BDBM555271(USRE49080, Example 69)
Affinity DataIC50: 1.20nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555253BDBM555253(USRE49080, Example 24)
Affinity DataIC50: 1.30nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555245BDBM555245(USRE49080, Example 11)
Affinity DataIC50: 1.40nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555254BDBM555254(USRE49080, Example 25)
Affinity DataIC50: 1.5nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555272BDBM555272(USRE49080, Example 71)
Affinity DataIC50: 1.5nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555267BDBM555267(USRE49080, Example 60)
Affinity DataIC50: 2.20nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555238BDBM555238(USRE49080, Example 1)
Affinity DataIC50: 2.70nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555269BDBM555269(USRE49080, Example 65)
Affinity DataIC50: 2.70nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555264BDBM555264(USRE49080, Example 43)
Affinity DataIC50: 3.90nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555246BDBM555246(USRE49080, Example 14)
Affinity DataIC50: 5.5nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555243BDBM555243(USRE49080, Example 9)
Affinity DataIC50: 7.20nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555267BDBM555267(USRE49080, Example 60)
Affinity DataIC50: 9nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555259BDBM555259(USRE49080, Example 35)
Affinity DataIC50: 9.5nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555258BDBM555258(USRE49080, Example 33)
Affinity DataIC50: 11nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555239BDBM555239(USRE49080, Example 2)
Affinity DataIC50: 11.1nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555265BDBM555265(USRE49080, Example 46)
Affinity DataIC50: 14nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555261BDBM555261(USRE49080, Example 38)
Affinity DataIC50: 14.4nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555240BDBM555240(USRE49080, Example 3)
Affinity DataIC50: 16nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555262BDBM555262(USRE49080, Example 41)
Affinity DataIC50: 16.2nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555266BDBM555266(USRE49080, Example 47)
Affinity DataIC50: 16.5nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555244BDBM555244(USRE49080, Example 10)
Affinity DataIC50: 18nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555272BDBM555272(USRE49080, Example 71)
Affinity DataIC50: 19nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 50560402BDBM50560402(Licogliflozin | Lik066 | LIK-066 | USRE49080, Exam...)
Affinity DataIC50: 22nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555260BDBM555260(USRE49080, Example 36)
Affinity DataIC50: 28nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555271BDBM555271(USRE49080, Example 69)
Affinity DataIC50: 37nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555254BDBM555254(USRE49080, Example 25)
Affinity DataIC50: 40nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555264BDBM555264(USRE49080, Example 43)
Affinity DataIC50: 59nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555241BDBM555241(USRE49080, Example 4)
Affinity DataIC50: 65nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555256BDBM555256(USRE49080, Example 29)
Affinity DataIC50: 84.5nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555270BDBM555270(USRE49080, Example 66)
Affinity DataIC50: 100nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555263BDBM555263(USRE49080, Example 42)
Affinity DataIC50: 105nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555258BDBM555258(USRE49080, Example 33)
Affinity DataIC50: 157nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555269BDBM555269(USRE49080, Example 65)
Affinity DataIC50: 170nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555257BDBM555257(USRE49080, Example 31)
Affinity DataIC50: 404nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555249BDBM555249(USRE49080, Example 17)
Affinity DataIC50: 480nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555247BDBM555247(USRE49080, Example 15)
Affinity DataIC50: 650nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555238BDBM555238(USRE49080, Example 1)
Affinity DataIC50: 655nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetSodium/glucose cotransporter 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 555242BDBM555242(USRE49080, Example 8)
Affinity DataIC50: 725nMAssay Description:The SGLT-2 assay is carried out as follows: CHO-hSGLT2 cells are cultivated in Ham's F12 Medium (BioWhittaker) with 10% foetal calf serum and 250...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

Displayed 1 to 50 (of 62 total ) | Next | Last >>
Jump to: